[1]
Pandey, P., Asava, A., Nagaraj, K.H., Rath, S.K. and Kodati, V.L. 2021. A prospective, single-arm, open-label study to determine the safety and effectiveness of a fixed-dose combination of camylofin and mefenamic acid in Indian women with primary dysmenorrhea. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 10, 9 (Aug. 2021), 3336–3341. DOI:https://doi.org/10.18203/2320-1770.ijrcog20213445.